BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 18439753)

  • 21. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
    Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
    Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The tumor suppressor Scrib selectively interacts with specific members of the zyxin family of proteins.
    Petit MM; Crombez KR; Vervenne HB; Weyns N; Van de Ven WJ
    FEBS Lett; 2005 Sep; 579(22):5061-8. PubMed ID: 16137684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
    Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
    Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Claudin-16 reduces the aggressive behavior of human breast cancer cells.
    Martin TA; Harrison GM; Watkins G; Jiang WG
    J Cell Biochem; 2008 Sep; 105(1):41-52. PubMed ID: 18442037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AJUBA and WTIP can compete with LIMD1 for junctional localization and LATS regulation.
    Kirichenko E; Irvine KD
    MicroPubl Biol; 2022; 2022():. PubMed ID: 36439396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRIP6 is required for tension at adherens junctions.
    Venkatramanan S; Ibar C; Irvine KD
    J Cell Sci; 2021 Mar; 134(6):. PubMed ID: 33558314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel BRCA2-Interacting Protein, LIMD1, Is Essential for the Centrosome Localization of BRCA2 in Esophageal Cancer Cell.
    Hou X; Li T; Ren Z; Liu Y
    Oncol Res; 2016; 24(4):247-53. PubMed ID: 27656835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LIMD1 phase separation contributes to cellular mechanics and durotaxis by regulating focal adhesion dynamics in response to force.
    Wang Y; Zhang C; Yang W; Shao S; Xu X; Sun Y; Li P; Liang L; Wu C
    Dev Cell; 2021 May; 56(9):1313-1325.e7. PubMed ID: 33891898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The LIM protein, Limd1, regulates AP-1 activation through an interaction with Traf6 to influence osteoclast development.
    Feng Y; Zhao H; Luderer HF; Epple H; Faccio R; Ross FP; Teitelbaum SL; Longmore GD
    J Biol Chem; 2007 Jan; 282(1):39-48. PubMed ID: 17092936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ability of the LIMD1 and TRIP6 LIM domains to bind strained f-actin is critical for their tension dependent localization to adherens junctions and association with the Hippo pathway kinase LATS1.
    Ray S; DeSilva C; Dasgupta I; Mana-Capelli S; Cruz-Calderon N; McCollum D
    Cytoskeleton (Hoboken); 2024 Mar; ():. PubMed ID: 38426816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted therapy for LIMD1-deficient non-small cell lung cancer subtypes.
    Davidson K; Grevitt P; Contreras-Gerenas MF; Bridge KS; Hermida M; Shah KM; Mardakheh FK; Stubbs M; Burke R; Casado P; Cutillas PR; Martin SA; Sharp TV
    Cell Death Dis; 2021 Nov; 12(11):1075. PubMed ID: 34764236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LIM-domain proteins, LIMD1, Ajuba, and WTIP are required for microRNA-mediated gene silencing.
    James V; Zhang Y; Foxler DE; de Moor CH; Kong YW; Webb TM; Self TJ; Feng Y; Lagos D; Chu CY; Rana TM; Morley SJ; Longmore GD; Bushell M; Sharp TV
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12499-504. PubMed ID: 20616046
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and clinical significance of LIMD-1 gene in adult patients with acute leukemia].
    Liao ZL; Liu L; Wang Y; Fan H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):34-8. PubMed ID: 25687042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silencing of LIMD1 promotes proliferation and reverses cell adhesion-mediated drug resistance in non-Hodgkin's lymphoma.
    Tang J; Zhu L; Huang Y; Shi B; Zhang S; Gu L; Zhao J; Deng M; Zhu J; Xun H; Wang Y; Wang C
    Oncol Lett; 2019 Mar; 17(3):2993-3000. PubMed ID: 30854077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA-mir3471-limd1 regulatory network plays critical roles in HIBD.
    Sun L; Wan J; Sun B; Tian Q; Li M; Xu LX; Feng CX; Tong X; Feng X; Yang X; Ding X
    Exp Brain Res; 2024 Feb; 242(2):443-449. PubMed ID: 38147087
    [TBL] [Abstract][Full Text] [Related]  

  • 37. METTL8 mRNA Methyltransferase Enhances Cancer Cell Migration via Direct Binding to ARID1A.
    Lee SA; Lee KH; Kim H; Cho JY
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LIM domain proteins in cell mechanobiology.
    Anderson CA; Kovar DR; Gardel ML; Winkelman JD
    Cytoskeleton (Hoboken); 2021 Jun; 78(6):303-311. PubMed ID: 34028199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Algorithm-Based Meta-Analysis Reveals the Mechanistic Interaction of the Tumor Suppressor LIMD1 With Non-Small-Cell Lung Carcinoma.
    Wang L; Sparks-Wallace A; Casteel JL; Howell MEA; Ning S
    Front Oncol; 2021; 11():632638. PubMed ID: 33869018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LIMD1 Increases the Sensitivity of Lung Adenocarcinoma Cells to Cisplatin via the GADD45α/p38 MAPK Signaling Pathway.
    Zeng X; Wang H; He D; Jia W; Ma R
    Front Oncol; 2020; 10():969. PubMed ID: 32754438
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.